Emil Tanghetti

Recent publications by Emil Tanghetti

1. Long-term efficacy and tolerability of clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for acne: pooled results from two 6-month studiesJournal of Dermatological Treatment · Sun,
2. Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination Halobetasol Propionate and TazaroteneJournal of Drugs in Dermatology · Tue,
3. Therapeutic Recommendations for the Treatment of Acne Vulgaris in the USSKIN The Journal of Cutaneous Medicine · Tue,
4. Impact of Age on Efficacy and Safety of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants with Moderate-to-Severe AcneSKIN The Journal of Cutaneous Medicine · Tue,
5. The Right Formula for Acne: Importance of Vehicle Formulation in Tazarotene 0.045% Lotion Design, Application, Tolerability, and EfficacyDermatologic Therapy · Thu,
6. Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 AnalysisDermatology and Therapy · Wed,
7. Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Clinical Efficacy and Application CharacteristicsSKIN The Journal of Cutaneous Medicine · Mon,
8. Efficacy and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne Vulgaris in Children and AdolescentsSKIN The Journal of Cutaneous Medicine · Mon,
9. Melanin-dependent tissue interactions induced by a 755-nm picosecond-domain laser: complementary visualization by optical imaging and histologyLasers in Medical Science · Fri,
10. Triple‐combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate‐to‐severe acne in children and adolescents: Randomized phase 2 studyPediatric Dermatology · Wed,